Lux Capital Page Not Found

In 2018, venture capital funds directed +$35B of investment to software, while directing $1.9B to synthetic biology. Why is this happening? Only 5% of people in Forbes 400 have formal scientific training, and it makes sense that people don't invest in things they don't understand. So this is a big problem.

The lack of quality data on investors has led to a sales-first-oriented venture environment where investors are overpromising and under-delivering.